Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kesuting syrup and Keqing capsule for mild to moderate COVID-19
ChiCTR2000029991Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kesuting and Keqing capsule in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Time to disappearance of cough. Started Feb 2020; status: recruiting.
02
Drugs
kesutingKeqing capsule
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000029991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029991.